The Danish Medicines Agency will be sending out acknowledgement letters and decisions to companies, researchers, etc. electronically, in so far as we have a registered email address for the person(s) that we primarily correspond with.
This is a consequence of our obligations related to ‘eDay3’. The purpose of eDay3 is to give citizens and companies in Denmark a significantly improved and more flexible service on the internet.
Danish Medicines Agency, 6 December 2010
